The U.S. Food and Drug Administration has approved AstraZeneca and partner Daiichi Sankyo's precision drug to treat a type of ...

The US Food and Drug Administration (FDA) has approved datopotamab deruxtecan for the treatment of certain patients with ...

It’s a sobering statistic: 1 in 8 women in the United States will be diagnosed with breast cancer during her lifetime.1 ...

As cancer treatment costs have increased, identifying and treating early-stage cancer sooner reduces expenses and improves ...

During a Case-Based Roundtable event, Laura Huppert, MD, reviewed antibody-drug conjugates for a patient with metastatic ...

Inside Edition' reporter Alison Hall undergoes a double mastectomy, after discovering her breast cancer while on assignment.

Cancer remains a leading cause of death globally, with breast cancer being the most fatal for women. A recent American Cancer ...

Genetic testing is recommended for those with personal and family histories of several types of cancer — including pancreatic ...

A new report shows that cancer cases are increasing in females in the United States and in younger adults. For the first time ...

"Based on data from the eight eligible studies from 2019 to 2023, the committee concludes that compared with never consuming ...

The approval is based on findings from the phase 3, multicenter, open-label, randomized TROPION-Breast01 trial.

And, in fact, this study showed that the additional palbociclib to this kind of treatment was able to significantly prolong PFS from the start of the maintenance treatment with a benefit in terms of ...